risankizumab
abbvie
['risan', 'crohn']
37. dr ryan ungaro on pros in the risankizumab trials for crohn s disease #acg2022 abdominal pain and stool frequency scores were reduced for the most part 
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.